Cargando…
NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy
SIMPLE SUMMARY: eIF4A-targeted translational inhibitors, such as silvestrol and its analogues, have emerged as strong anticancer therapies. Here, we tested the efficacy of eIF4A inhibition across a large and diverse panel of cancer cell lines and found B cell lymphomas to be the most sensitive group...
Autores principales: | Sanghvi, Viraj R., Mohan, Prathibha, Singh, Kamini, Cao, Linlin, Berishaj, Marjan, Wolfe, Andrew L., Schatz, Jonathan H., Lailler, Nathalie, de Stanchina, Elisa, Viale, Agnes, Wendel, Hans-Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915661/ https://www.ncbi.nlm.nih.gov/pubmed/33562682 http://dx.doi.org/10.3390/cancers13040639 |
Ejemplares similares
-
Frequent 4EBP1 Amplification Induces Synthetic Dependence on FGFR Signaling in Cancer
por: Mohan, Prathibha, et al.
Publicado: (2022) -
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer
por: Wolfe, Andrew L., et al.
Publicado: (2014) -
Rapamycin-Induced Feedback Activation of eIF4E-EIF4A Dependent mRNA Translation in Pancreatic Cancer
por: Nguyen, Trang Uyen, et al.
Publicado: (2023) -
c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma
por: Singh, Kamini, et al.
Publicado: (2019) -
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapy
por: Oricchio, Elisa, et al.
Publicado: (2014)